Peer Review reports
From: GBAP1 functions as a tumor promotor in hepatocellular carcinoma via the PI3K/AKT pathway
| Original Submission | ||
|---|---|---|
| 8 Oct 2022 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| 16 Nov 2022 | Reviewed | Reviewer Report |
| 28 Nov 2022 | Reviewed | Reviewer Report - Binhui Xie |
| 14 Jan 2023 | Author responded | Author comments - Rong Chen |
| Resubmission - Version 4 | ||
| 14 Jan 2023 | Submitted | Manuscript version 4 |
| 30 Jan 2023 | Author responded | Author comments - Rong Chen |
| Resubmission - Version 5 | ||
| 30 Jan 2023 | Submitted | Manuscript version 5 |
| 3 Feb 2023 | Author responded | Author comments - Rong Chen |
| Resubmission - Version 6 | ||
| 3 Feb 2023 | Submitted | Manuscript version 6 |
| 16 Feb 2023 | Author responded | Author comments - Rong Chen |
| Resubmission - Version 7 | ||
| 16 Feb 2023 | Submitted | Manuscript version 7 |
| 7 Mar 2023 | Reviewed | Reviewer Report |
| 10 Mar 2023 | Reviewed | Reviewer Report - Binhui Xie |
| 11 Apr 2023 | Author responded | Author comments - Rong Chen |
| Resubmission - Version 8 | ||
| 11 Apr 2023 | Submitted | Manuscript version 8 |
| 4 May 2023 | Reviewed | Reviewer Report |
| Resubmission - Version 9 | ||
| Submitted | Manuscript version 9 | |
| Publishing | ||
| 23 Jun 2023 | Editorially accepted | |
| 5 Jul 2023 | Article published | 10.1186/s12885-023-11107-7 |
You can find further information about peer review here.